What it is
- A synthetic peptide analog of a fragment of adrenocorticotropic hormone (ACTH 4-10), developed in Russia.
What researchers have investigated
- Used clinically in Russia for certain neurological conditions; studied in animal models and some human studies there.
Type of evidence
- Animal research and human studies largely from a single country, with limited independent replication.
What remains unknown
- Efficacy and safety under rigorous international trial standards.
Safety & regulatory context
- Not FDA approved in the United States. Verify status individually.
Inclusion does not imply availability.
Level Health does not sell, prescribe or recommend Semax. Findings in animals or cells do not establish benefits in people.
Primary sources: PubMed search for Semax. Reviewed by: pending. Last reviewed: pending.